Find uplifting stories about heroes, innovations, and solutions
3984 results for "cancer vaccine"
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
A personalized mRNA vaccine helped 11 women with aggressive breast cancer stay cancer-free for up to six years. The groundbreaking treatment trained their immune systems to recognize and fight cancer cells using their own tumor's genetic code.
For the first time in history, cervical cancer deaths fell to zero among women aged 20-24 in England. The breakthrough proves we can actually prevent cancer through vaccination.
A groundbreaking cancer vaccine has nearly eliminated cervical cancer in young women, with doctors reporting they rarely see the disease in patients under 25 anymore. The success story reveals how vaccines can prevent cancer and save lives.
A groundbreaking breast cancer vaccine has received patent approval in South Korea, marking a major step toward preventing the world's most common cancer in women. The vaccine showed promising safety results and immune responses in 74% of trial participants.
A groundbreaking 18-year study from Sweden shows the HPV vaccine provides lasting protection against cervical cancer, with no signs of weakening over time. Nearly a million women participated in research that could help eliminate cervical cancer as a public health threat.
A woman's dog detected her breast cancer by pressing his nose to a lump on her chest. Now she's part of a groundbreaking vaccine trial that could prevent aggressive breast cancer from returning.
Cervical cancer is one of the most preventable cancers, yet it claims thousands of lives each year. A safe, proven vaccine could change that story completely.
After political backlash threatened to derail cancer research, mRNA vaccines are delivering real hope to patients with deadly diseases like pancreatic cancer. New funding and positive trial results suggest the technology could save thousands of lives.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, helped patients live twice as long as usual in a groundbreaking trial. One patient remains cancer-free nearly five years later.
Young women who get the HPV vaccine in their early teens have virtually no risk of dying from cervical cancer before age 30. This groundbreaking research proves the vaccine is even more life-saving than scientists initially believed.
For the first time ever, zero women aged 20-24 died from cervical cancer in the UK over a five-year period, thanks to routine HPV vaccination. Without the vaccine, 23 deaths would have been expected during that time.
For the first time ever, zero women in their early 20s died from cervical cancer in England over a four-year period. Scientists credit the HPV vaccine with reducing cervical cancer death risk before age 30 to "effectively zero."
Young women vaccinated against HPV at age 12-13 now have close to zero risk of dying from cervical cancer before 30. A landmark study from England shows the vaccine has already saved around 200 lives since 2008.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, doubled survival rates in early trials and kept one patient cancer-free for nearly five years. The vaccine trains each patient's immune system to recognize up to 40 unique cancer proteins, making it harder for tumors to hide.
A groundbreaking vaccine targeting a common mutation in deadly brain tumors helped two-thirds of patients survive eight years in a clinical trial. The treatment trains the immune system to hunt down cancer cells carrying the genetic error found in most gliomas. ##
Every woman from a small 2000s breast cancer vaccine trial is alive today, decades past typical survival odds. Scientists now know why their immune systems stayed cancer-ready for 20 years.
After 25 years at NBC News, Kristen Dahlgren left her dream job to solve a problem she discovered during her own breast cancer treatment: life-saving vaccine research wasn't reaching patients fast enough. Now she's partnering with one of America's top cancer research institutes to change that.
A personalized mRNA vaccine helped eight pancreatic cancer patients generate powerful immune responses, and seven of them are still alive six years later. The breakthrough offers new hope for one of the deadliest cancers, where fewer than 13% of patients survive five years.
For the first time ever, no women aged 20 to 24 died from cervical cancer in England over a five-year period. The HPV vaccine given to schoolgirls since 2008 has saved around 200 lives and given vaccinated children "close to zero" risk of dying from the disease before age 30.
Showing 20 of 3984